Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Stefania Signorelli"'
Autor:
Caterina Riillo, Nicoletta Polerà, Maria Teresa Di Martino, Giada Juli, Craig A. Hokanson, Tatjana Odineca, Stefania Signorelli, Katia Grillone, Serena Ascrizzi, Antonia Mancuso, Nicoletta Staropoli, Basilio Caparello, Maria Cerra, Giuseppe Nisticò, Pierosandro Tagliaferri, Roberto Crea, Daniele Caracciolo, Pierfrancesco Tassone
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-13 (2023)
Abstract Background Pronectins™ are a new class of fibronectin-3-domain 14th-derived (14Fn3) antibody mimics that can be engineered as bispecific T cell engager (BTCE) to redirect immune effector cells against cancer. We describe here the in vitro
Externí odkaz:
https://doaj.org/article/0787a02d83dd4274bb7935635c4bf039
Autor:
Melissa Papa, Lorenzo Scarpellini, Danitza Pradelli, Anna Maria Zanaboni, Alessia Mattia, Elisabetta Boz, Cecilia Rossi, Stefania Signorelli, Viviana Forti, Martina Longobardi, Beatrice Pasquinelli, Maria Celeste Gendusa, Davide Gamba, Claudio Maria Bussadori
Publikováno v:
Veterinary Sciences, Vol 10, Iss 12, p 669 (2023)
This retrospective cohort study included one hundred fifty-seven medium and large-size dogs with the aim of evaluating the effect of signalment and echocardiographic features on complications, outcomes and left ventricular modifications before and af
Externí odkaz:
https://doaj.org/article/f739cebbf426411aac6038362b026c33
Autor:
Tassone, Nicoletta Polerà, Antonia Mancuso, Caterina Riillo, Daniele Caracciolo, Stefania Signorelli, Katia Grillone, Serena Ascrizzi, Craig A. Hokanson, Francesco Conforti, Nicoletta Staropoli, Luigia Gervasi, Maria Teresa Di Martino, Mariamena Arbitrio, Giuseppe Nisticò, Roberto Crea, Pierosandro Tagliaferri, Giada Juli, Pierfrancesco
Publikováno v:
Cancers; Volume 15; Issue 6; Pages: 1647
Sarcomas are heterogeneous malignancies with limited therapeutic options and a poor prognosis. We developed an innovative immunotherapeutic agent, a first-in-class Pronectin™-based Bispecific T-Cell Engager (pAXL×CD3ε), for the targeting of AXL,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::e68a37531bf3cb17bdfe376167ffa022
Autor:
Ferdinando Noto, Cecilia Rossi, Lisa Gatti, E. Boz, Giulia Dravelli, Mariaceleste Gendusa, Stefania Signorelli, Danilo Caristi, Stefano Oricco, Melissa Papa, Claudio Bussadori
Publikováno v:
Journal of Veterinary Cardiology. 39:1-7
Pulmonic stenosis is a frequent congenital heart disease in dogs, and the treatment of choice is balloon valvuloplasty which is usually safe and successful. The authors describe for the first time a severe complication after balloon valvuloplasty in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3bc8fecf6d7a3e437fbeb4fa3a44fc3d
https://doi.org/10.1016/j.jvc.2021.10.005
https://doi.org/10.1016/j.jvc.2021.10.005
Autor:
Nicoletta Polerà, Antonia Mancuso, Caterina Riillo, Daniele Caracciolo, Stefania Signorelli, Katia Grillone, Serena Ascrizzi, Craig A. Hokanson, Francesco Conforti, Nicoletta Staropoli, Luigia Gervasi, Maria Teresa Di Martino, Mariamena Arbitrio, Giuseppe Nisticò, Roberto Crea, Pierosandro Tagliaferri, Giada Juli, Pierfrancesco Tassone
Publikováno v:
Cancers. 15:1647
Sarcomas are heterogeneous malignancies with limited therapeutic options and a poor prognosis. We developed an innovative immunotherapeutic agent, a first-in-class Pronectin™-based Bispecific T-Cell Engager (pAXL×CD3ε), for the targeting of AXL,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e570facbe524e0b22382fcca7e68205c
https://doi.org/10.3390/cancers15061647
https://doi.org/10.3390/cancers15061647